Early-stage antibiotic discovery happens mostly in academia, but limited funding and expertise hinder its translation into preclinical development.
In her REVIVE @gardp.bsky.social article, Olga Genilloud explores solutions to these issues.

🔗 Read more: https://revive.gardp.org/how-can-we-close-the-early-discovery-gap-and-improve-our-ability-to-discover-new-antibiotics/